Canada - français - Health Canada

hoffmann-la roche limited - tocilizumab - solution - 162mg - tocilizumab 162mg - disease-modifying antirheumatic agents

Canada - français - Health Canada

novartis pharmaceuticals canada inc - secukinumab - poudre pour solution - 150mg - secukinumab 150mg - misc. skin and mucous membrane agents

Canada - français - Health Canada

novartis pharmaceuticals canada inc - secukinumab - solution - 150mg - secukinumab 150mg - misc. skin and mucous membrane agents

Canada - français - Health Canada

hoffmann-la roche limited - tocilizumab - solution - 80mg - tocilizumab 80mg - disease-modifying antirheumatic agents

Canada - français - Health Canada

hoffmann-la roche limited - tocilizumab - solution - 200mg - tocilizumab 200mg - disease-modifying antirheumatic agents

Canada - français - Health Canada

hoffmann-la roche limited - tocilizumab - solution - 400mg - tocilizumab 400mg - disease-modifying antirheumatic agents

Canada - français - Health Canada

hoffmann-la roche limited - tocilizumab - solution - 162mg - tocilizumab 162mg - disease-modifying antirheumatic agents

Canada - français - Health Canada

heron therapeutics, inc. - méloxicam; bupivacaïne - solution (à libération prolongée) - 6mg; 200mg - méloxicam 6mg; bupivacaïne 200mg

Canada - français - Health Canada

heron therapeutics, inc. - méloxicam; bupivacaïne - solution (à libération prolongée) - 9mg; 300mg - méloxicam 9mg; bupivacaïne 300mg

Canada - français - Health Canada

heron therapeutics, inc. - méloxicam; bupivacaïne - solution (à libération prolongée) - 12mg; 400mg - méloxicam 12mg; bupivacaïne 400mg